Although several studies suggested that PD-L1 might be associated with the clinical outcome of GC patients, our analysis of TCGA data demonstrated that PD-1 and PD-L2 might be a prognostic marker for GC. This evidence concerns the gene PDCD1LG2 and gastric cancer.